Financhill
Back

Tonix Pharmaceuticals Holding 10K Form

Sell
50

TNXP
Tonix Pharmaceuticals Holding

Last Price:
0.19
Seasonality Move:
3.87%

7 Day Trial

ALL ACCESS PASS

$ 7

Receive TNXP News And Ratings

See the #1 stock for the next 7 days that we like better than TNXP

TNXP Financial Statistics

Sales & Book Value

Annual Sales: $7.77M
Cash Flow: $-18.81M
Price / Cash Flow: 0
Annual Sales: $0.48
Price / Book: 0.33

Profitability

EPS (TTM): -101.00000
Net Income (TTM): $-135.25M
Gross Margin: $3.03M
Return on Equity: -150.01%
Return on Assets: -113.77%

Tonix Pharmaceuticals Holding Earnings Forecast

Key Tonix Pharmaceuticals Holding Financial Ratios

  • The Gross Profit Margin over the past 16 years for TNXP is 38.97%.
  • The Selling, General & Administrative Expenses for TNXP have been equal to 447.37% of Gross Profit Margin.
  • The Research & Development expenses have been 1,115.54% of Revenue.
  • The Interest Expense is 0.00% of Operating Income.
  • Per Share Earnings over the last 16 years have been positive in 10 years.

Tonix Pharmaceuticals Holding Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Industry: Biotechnology
Sector: Health Care
Current Symbol: TNXP
CUSIP: 890260
Website: tonixpharma.com

Debt

Debt-to-Equity Ratio: 0.11
Current Ratio: 3.33
Quick Ratio: 2.52

Price-to-Earnings

Trailing P/E Ratio: 0
Forward P/E Ratio: 0

TNXP Technical Analysis vs Fundamental Analysis

Sell
50
Tonix Pharmaceuticals Holding (TNXP) is a Sell

Is Tonix Pharmaceuticals Holding a Buy or a Sell?